These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6078562)

  • 1. [Laboratory studies on the Russian BCG vaccine and comparison with th Polish vaccine prepared from the Brazilian substrain].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1967 Jul; 35(7):609-18. PubMed ID: 6078562
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of biological properties of BCG vaccines used in Poland 1964-1968].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1969 Oct; 37(10):901-6. PubMed ID: 5366981
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests].
    Janaszek W
    Przegl Epidemiol; 1994; 48(3):285-92. PubMed ID: 7938633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory characteristics of BCG vaccine (from Brasilian and French substrains) produced in Poland and of the original Soviet vaccine].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Pediatr Pol; 1969 Dec; 44(12):1469-76. PubMed ID: 5371124
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the BCG vaccine produced in Poland and BCG vaccines produced from BCG substrains of various origin.
    Buraczewska M; Kurylowicz W; Paklerska-Pobratyn H
    Pol Med J; 1966; 5(1):95-102. PubMed ID: 5935446
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test".
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Pol Med J; 1969; 8(5):1136-42. PubMed ID: 4245977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protective value of the BCG vaccine use in general antituberculosis vaccination in Poland according to laboratory studies].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1966 Jul; 34(7):685-7. PubMed ID: 5955829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of Soviet and Bulgarian BCG vaccines].
    Iablokova TB; Rozenberg AM; Pisarenko NN; Nesterenko LA; Engibarov A
    Probl Tuberk; 1980 Jun; (6):60-4. PubMed ID: 7393916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative laboratory evaluation of the protective properties of French and Braziliam BCG substrains and of vaccines produced from these strains in Poland].
    Szulkin E
    Med Dosw Mikrobiol; 1966; 18(4):345-52. PubMed ID: 5334256
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of Polish, Russian and Hungarian BCG vaccines. I. Evaluation of the allergenic properties of the vaccines after 16 weeks].
    Szczuka I; Olakowski T
    Pneumonol Pol; 1983; 51(8-9):441-7. PubMed ID: 6647051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of Polish, Russian and Hungarian BCG vaccines. II. Evaluation of the allergenic properties of the vaccines after 26 weeks and 30 months].
    Szczuka I; Olakowski T
    Pneumonol Pol; 1983; 51(8-9):449-59. PubMed ID: 6647052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlled trials of BCG vaccination of newborn infants with BCG vaccine prepared from the French BCG substrain in Warsaw].
    Olakowski T; Iwanowa O; Mardoń K
    Gruzlica; 1972 May; 40(5):403-9. PubMed ID: 5030596
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the morphology of colonies of bacilli of BCG-Poland substrain. II. Dissociation of BCG-Poland substrain on Löwenstein-Jensen egg medium.
    Lipińska R; Rzucidło L
    Acta Microbiol Pol; 1978; 27(3):277-85. PubMed ID: 81601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination of protein MPB 70 properties in BCG substrains used for the production of Polish antituberculosis vaccines].
    Janaszek W; Wysokińska T; Aleksandrowicz J
    Med Dosw Mikrobiol; 1998; 50(1-2):47-54. PubMed ID: 9857613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):97-105. PubMed ID: 6369043
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222.
    Bachvarova M; Stefanova T; Nikolaeva S; Chouchkova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):1010-5. PubMed ID: 19393344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno BCG Pasteur F vaccine.
    Gheorghiu M; Chambon L; Serié C; Juvin-Calmette D
    Dev Biol Stand; 1977 Apr 13-15; 38():29-37. PubMed ID: 608512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology of colonies of the BCG Poland substrain. II. Dissociation of BCG Poland substrain on Löwenstein-Jensen egg medium].
    Lipińska R; Rzucidlo L
    Gruzlica; 1974 Sep; 42(9):857-62. PubMed ID: 4605797
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.